In addition, due to clinical inertia in the management of T2D, basal insulin is commonly not initiated until the later course of antidiabetic treatment, that is, when treatment with multiple oral glucose-lowering agents (GLAs) has failed11. This evidence concerns the gene INS and type 2 diabetes mellitus.